日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC

度伐利尤单抗联合放化疗治疗不可切除的III期非小细胞肺癌的真实世界5年疗效

Girard, N; Bar, J; Baas, P; Chouaid, C; Christoph, D C; Field, J K; Fietkau, R; Garassino, M C; Garrido Lopez, P; Gregorc, V; Haakensen, V D; Hiltermann, T J N; Kao, S; McDonald, F; Mornex, F; Moskovitz, M; Peters, S; Siva, S; Solomon, B; Qiao, Y; Anand, S; Chander, P; Shcherbakova, T; Diaz Perez, I; Filippi, A R

Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy

PACIFIC-R 研究是一项真实世界研究,旨在探讨接受度伐利尤单抗治疗的不可切除的 III 期非小细胞肺癌患者在接受放化疗后发生放射性肺炎的放射治疗模式和相关因素。

Filippi, Andrea R; Bar, Jair; Christoph, Daniel C; Field, John K; Fietkau, Rainer; Garassino, Marina Chiara; Garrido, Pilar; Haakensen, Vilde Drageset; Kao, Steven; McDonald, Fiona; Mornex, Francoise; Moskovitz, Mor; Peters, Solange; Van Den Heuvel, Michel M; Vercauter, Piet; Smit, Hans J M; Solomon, Benjamin; Chander, Pratibha; Qiao, Yao; Faria, Jolyon; Girard, Nicolas

How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?

肺功能如何影响接受放化疗和度伐利尤单抗治疗的局部晚期非小细胞肺癌患者的生活质量?

Sommervoll, Frigg Å; Horndalsveen, Henrik; Sommervoll, Dag Einar; Koivonen, Jussi; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning; Aanerud, Marianne; Cicenas, Saulius; Helbekkmo, Nina; Ahvonen, Jarkko; Silvoniemi, Maria; Barrera, Gina; Bjaanæs, Maria M; Haakensen, Vilde; Öjlert, Åsa; Oselin, Kersti; Helland, Åslaug; Madebo, Tesfaye

Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine

基于[18F]FDG PET/CT对接受伊匹木单抗和纳武利尤单抗+/- UV1端粒酶疫苗治疗的胸膜间皮瘤患者进行预后预测

Thunold, Solfrid; Hernes, Eivor; Farooqi, Saima; Öjlert, Åsa Kristina; Francis, Roslyn J; Nowak, Anna K; Szejniuk, Weronika Maria; Nielsen, Søren Steen; Cedres, Susana; Perdigo, Marc Simo; Sørensen, Jens Benn; Meltzer, Carin; Mikalsen, Lars Tore Gyland; Helland, Åslaug; Malinen, Eirik; Haakensen, Vilde Drageset

Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab

血液肿瘤突变负荷作为不可切除的非小细胞肺癌患者接受放化疗和度伐利尤单抗治疗的生物标志物

Horndalsveen, Henrik; Haakensen, Vilde Drageset; Madebo, Tesfaye; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Koivunen, Jussi; Oselin, Kersti; Cicenas, Saulius; Helbekkmo, Nina; Aanerud, Marianne; Ahvonen, Jarkko; Silvoniemi, Maria; Bjaanæs, Maria Moksnes; Farooqi, Saima; Nebdal, Daniel; Dalsgaard, Astrid Marie; Danielsen, Britina Kjuul; Børve, Mari; Dalen, Tonje Sofie; Öjlert, Åsa Kristina; Helland, Åslaug

Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R

接受放化疗后接受度伐利尤单抗治疗的不可切除III期非小细胞肺癌患者的真实世界疗效:PACIFIC-R研究的总生存期中期分析

Filippi, A R; Bar, J; Chouaid, C; Christoph, D C; Field, J K; Fietkau, R; Garassino, M C; Garrido, P; Haakensen, V D; Kao, S; Markman, B; McDonald, F; Mornex, F; Moskovitz, M; Peters, S; Sibille, A; Siva, S; van den Heuvel, M; Vercauter, P; Anand, S; Chander, P; Licour, M; de Lima, A R; Qiao, Y; Girard, N

Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma

血清细胞因子作为胸膜间皮瘤患者免疫检查点抑制剂毒性的生物标志物

Farooqi, Saima Jamil; Zhao, Zhi; Öjlert, Åsa Kristina; Thunold, Solfrid; Juul, Hedvig Vidarsdotter; Bjaanæs, Maria Moksnes; Horndalsveen, Henrik; Nymoen, Hanne Marte Gjertsen; Helland, Åslaug; Haakensen, Vilde Drageset

Thoracic radiation in combination with erlotinib-results from a phase 2 randomized trial

胸部放射治疗联合厄洛替尼治疗——一项 II 期随机试验的结果

Nymoen, Hanne Marte; Alver, Tine Norman; Horndalsveen, Henrik; Eide, Hanne Astrid; Bjaanæs, Maria Moksnes; Brustugun, Odd Terje; Grønberg, Bjørn Henning; Haakensen, Vilde Drageset; Helland, Åslaug

Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial

阿特珠单抗联合立体定向放射治疗晚期非小细胞肺癌患者:安全性、临床活性和ctDNA反应——ComIT-1试验

Horndalsveen, Henrik; Alver, Tine Norman; Dalsgaard, Astrid Marie; Rogg, Lotte Victoria; Helbekkmo, Nina; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Ramberg, Christina; Haakensen, Vilde Drageset; Öjlert, Åsa Kristina; Bjaanaes, Maria Moksnes; Helland, Åslaug

Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC

局部晚期非小细胞肺癌患者接受根治性放化疗后未能开始度伐利尤单抗巩固治疗的相关因素

Langberg, Christian Wilhelm; Horndalsveen, Henrik; Helland, Åslaug; Haakensen, Vilde Drageset